The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The burden of atopic dermatitis: summary of a report for the National Eczema Association.
Open accessAbstract
To assess the patient-level and societal burden of atopic dermatitis, we comprehensively reviewed the literature related to quality of life, social, economic, academic, and occupational impacts. Atopic dermatitis has profound impacts on patient and family quality of life. A conservative estimate of the annual costs of atopic dermatitis in the United States is $5.297 billion (in 2015 USD). People with atopic dermatitis may change their occupation because of their skin disease. Research gaps include quality of life assessments outside of tertiary care centers, impacts on partners and families of adult patients, and updated comprehensive cost estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Atopic dermatitis (AD), or atopic eczema, is a chronic, recurrent, and multifactorial inflammatory disease characterized by eczema, dry skin (xerosis), and pruritus in variable degree, but generally intense, which compromises different dimensions of quality of life: symptomatic, functional, emotional, interpersonal and professional relationships.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [1]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bickers (2006) · doi:10.1016/j.jaad.2006.05.048 · Cited by 741
Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health
Shaw, T., Currie, G. P., Koudelka, C. W., & Simpson, E. L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.251 · Cited by 721
Beattie, P. E., & Lewis-Jones, M. S. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07185.x · Cited by 526
Silverberg, J. I., Garg, N. K., Paller, A. S., Fishbein, A. B., & Zee, P. C. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.325 · Cited by 346
Patient perspectives on the management of atopic dermatitis
Zuberbier, T., Orlow, S. J., Paller, A. S., Taı̈eb, A., Allen, R., Hermosa, J. M. H., Ocampo‐Candiani, J., Cox, M., Langeraar, J., & Simon, J. C. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.031 · Cited by 343
Effects of Atopic Dermatitis on Young American Children and Their Families
Chamlin, S. L., Frieden, I. J., Williams, M. L. K., & Chren, M. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0374 · Cited by 316
Atopic dermatitis is associated with a decrement in health‐related quality of life
Kiebert, G. M., Sorensen, S. V., Revicki, D. A., Fagan, S. C., Doyle, J. J., Cohen, J. L., & Fivenson, D. P. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01436.x · Cited by 287
Persistence of Mild to Moderate Atopic Dermatitis
Margolis, J. S., Abuabara, K., Bilker, W. B., Hoffstad, O., & Margolis, D. J. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.10271 · Cited by 277
Life quality assessment among patients with atopic eczema
Holm, E., Wulf, H. C., Stegmann, H., & Jemec, G. B. E. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07050.x · Cited by 227
Relationship between itch and psychological status of patients with atopic dermatitis
Chrostowska‐Plak, D., Reich, A., & Szepietowski, J. C. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04578.x · Cited by 210
Cited by
Sorted by citations
Items 101–200 of 728
The multidimensional burden of atopic dermatitis
Bridgman, A. C., Block, J. K., & Drucker, A. M. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.03.009 · Cited by 44
Self-citationEmollients for prevention of atopic dermatitis in infancy
Perrett, K. P., & Peters, R. L. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33174-5 · Cited by 43
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Bernardo, D., Bieber, T., & Torres, T. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00793-5 · Cited by 43
Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study
Xue, Y., Zhang, L., Chen, Y., Wang, H., & Xie, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1174331 · Cited by 43
Grant, L., Larsen, L. S., Trennery, C., Silverberg, J. I., Abramovits, W., Simpson, E. L., Stalder, J.-F., Paty, J. A., Hahn-Pedersen, J. H., Kragh, N., et al. (2019) · Dermatitis · doi:10.1097/der.0000000000000486 · Cited by 43
Simpson, E. L., Guttman‐Yassky, E., Eichenfield, L. F., Boguniewicz, M., Bieber, T. R. M., Schneider, S. K. R., Guana, A., & Silverberg, J. I. (2023) · Allergy · doi:10.1111/all.15811 · Cited by 42
Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report
Schoch, J. J., Anderson, K., Jones, A. E., Tollefson, M. M., Dermatology, S. O., Wright, T., Hunt, R. D., Lauren, C. T., Boull, C. L., Gupta, D., et al. (2025) · PEDIATRICS · doi:10.1542/peds.2025-071812 · Cited by 42
Impacto económico de la dermatitis atópica en adultos: estudio de base poblacional (estudio IDEA)
Sicras‐Mainar, A., Navarro‐Artieda, R., & Carrascosa, J. M. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2017.09.003 · Cited by 42
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
Eshtiaghi, P., & Gooderham, M. (2018) · Core evidence · doi:10.2147/ce.s133661 · Cited by 42
Silverberg, J. I., Thyssen, J. P., Simpson, E. L., Yosipovitch, G., Ständer, S., Valdez, H., Rojo, R., Biswas, P., Myers, D. E., Feeney, C., et al. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00604-9 · Cited by 42
A new era of atopic eczema research: Advances and highlights
Hülpüsch, C., Weins, A. B., Traidl‐Hoffmann, C., & Reiger, M. (2021) · Allergy · doi:10.1111/all.15058 · Cited by 44
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis
Jang, Y. H., Choi, E.-Y., Lee, H., Woo, J., Park, S., Noh, Y., Jeon, J., Yoo, E.-Y., Shin, J., & Lee, Y. W. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.23563 · Cited by 41
Recent Developments in Atopic Dermatitis
Yang, E., Sekhon, S., Sanchez, I. M., Beck, K. M., & Bhutani, T. (2018) · PEDIATRICS · doi:10.1542/peds.2018-1102 · Cited by 40
Burden of Atopic Dermatitis in Swedish Adults: A Population-based Study
Theodosiou, G., Montgomery, S., Metsini, A., Dalgard, F. J., Svensson, �., & von Kobyletzki, L. B. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3257 · Cited by 40
The Challenge of Basic Itch Research
Carstens, E., Follansbee, T., & Carstens, M. I. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3343 · Cited by 40
Portulaca oleracea L. extracts alleviate 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice
Lv, W.-J., Huang, J., Li, S.-P., Gong, X.-P., Sun, J.-B., Mao, W., & Guo, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.986943 · Cited by 40
IL-4Rα Inhibitor for Atopic Disease
Chang, H. Y., & Nadeau, K. C. (2017) · Cell · doi:10.1016/j.cell.2017.06.046 · Cited by 39
Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review
Huet, F., Severino‐Freire, M., Chéret, J., Gouin, O., Praneuf, J., Pierre, O., Misery, L., & Gall‐Ianotto, C. L. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.11.015 · Cited by 39
Atopic dermatitis and alcohol use – a meta‐analysis and systematic review
Halling, A., Hamann, C. R., Holm, R. P., Linneberg, A. R., Silverberg, J. I., Egeberg, A., & Thyssen, J. P. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14814 · Cited by 39
Vermeulen, F. M., Gerbens, L. A. A., Bosma, A. L., Apfelbacher, C., Irvine, A. D., Arents, B. W. M., Barbarot, S., Deleuran, M. S., Eichenfield, L. F., Manca, A., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17715 · Cited by 39
New and Emerging Therapies for Pediatric Atopic Dermatitis
Nguyen, H. L., Anderson, K., & Tollefson, M. M. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00342-w · Cited by 41
Personalized prediction of daily eczema severity scores using a mechanistic machine learning model
Hurault, G., Domínguez‐Hüttinger, E., Langan, S., Williams, H. C., & Tanaka, R. J. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13717 · Cited by 40
Park, H., Ahn, S., Lee, H., Hahm, D., Kim, K., & Yeom, M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.027 · Cited by 39
Topical therapy of atopic dermatitis with a focus on pimecrolimus
Luger, T. A., Paller, A. S., Irvine, A. D., Sidbury, R., Eichenfield, L. F., Werfel, T., & Bieber, T. R. M. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17272 · Cited by 42
The Sebaceous Gland: A Key Player in the Balance Between Homeostasis and Inflammatory Skin Diseases
Mosca, S., Ottaviani, M., Briganti, S., Nardo, A. D., & Flori, E. (2025) · Cells · doi:10.3390/cells14100747 · Cited by 41
The Psychosocial Impact of Atopic Dermatitis
Gochnauer, H. R., Valdés‐Rodríguez, R., Cardwell, L. A., & Anolik, R. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-64804-0_6 · Cited by 38
Health-related Quality of Life and Mental Health of Adults With Atopic Dermatitis
Kwak, Y., & Kim, Y. (2017) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2017.06.001 · Cited by 38
Importance of out‐of‐pocket costs for adult patients with atopic dermatitis in France
Launois, R., Ezzedine, K., Cabout, E., Reguai, Z., Merrhand, S., Héas, S., Sénéschal, J., Misery, L., & TAIEB, C. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15581 · Cited by 38
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
Lytvyn, Y., & Gooderham, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020568 · Cited by 39
Depression and anxiety in patients with atopic dermatitis
LeBovidge, J., & Schneider, L. C. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.02.017 · Cited by 37
Andersen, L., Nyeland, M. E., & Nyberg, F. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18451 · Cited by 37
The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets
Paolo, C. T. D., Diamandis, E. P., & Prassas, I. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1775171 · Cited by 38
Le, M., Berman-Rosa, M., Ghazawi, F. M., Bourcier, M., Fiorillo, L., Gooderham, M., Guenther, L., Hanna, S., Hong, H., Landells, I. D. R., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.682547 · Cited by 37
Topical anti-inflammatory treatments for eczema: network meta-analysis
Lax, S. J., Vogt, E. V., Candy, B., Steele, L., Reynolds, C. M., Stuart, B. L., Parker, R., Axon, E., Roberts, A., Doyle, M., et al. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015064.pub2 · Cited by 38
Self-citationChildhood atopic dermatitis: current developments, treatment approaches, and future expectations
Çetinkaya, P. G., & Şahiner, Ü. M. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1810-105 · Cited by 36
Wan, J., Shin, D. B., Syed, M. N., Abuabara, K., Lemeshow, A. R., & Gelfand, J. M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18564 · Cited by 35
The Impact of Air Pollution on Atopic Dermatitis
Lai, A., Owens, K. E., Patel, S., & Nicholas, M. W. (2023) · Current Allergy and Asthma Reports · doi:10.1007/s11882-023-01095-w · Cited by 39
Zhao, M., Liang, Y., Shen, C., Wang, Y., Ma, L., & Ma, X. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00365-z · Cited by 34
Kim, Y. S., Go, G., Yun, C.-W., Yea, J.-H., Yoon, S., Han, S.-Y., Lee, G., Lee, M., & Lee, S. H. (2021) · Biomolecules · doi:10.3390/biom11101450 · Cited by 34
McDonald, V. M., Hamada, Y., Agustí, A. G. N., & Gibson, P. G. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.01.020 · Cited by 34
Economic Impact of Atopic Dermatitis in Adults: A Population-Based Study (IDEA Study)
Sicras‐Mainar, A., Navarro‐Artieda, R., & Carrascosa, J. M. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2017.11.020 · Cited by 33
Drucker, A. M., Pope, E. I., Field, A. E., Qureshi, A. A., Dumas, O., & Camargo, C. A. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.10.044 · Cited by 33
Self-citationMihara, R., Kabashima, K., Furue, M., Nakano, M., & Ruzicka, T. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14934 · Cited by 32
Prenatal Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Childhood Atopic Dermatitis
Gardner, K. G., Gebretsadik, T. S., Hartman, T. J., Rosa, M. J., Tylavsky, F. A., Adgent, M. A., Moore, P. E., Koçak, M., Bush, N. R., Davis, R. L., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.031 · Cited by 32
Going, Toll-like receptors in skin inflammation and inflammatory diseases
Kumar, V. (2020) · EXCLI journal · doi:10.17179/excli2020-3114 · Cited by 32
Insights into atopic dermatitis pathogenesis lead to newly approved systemic therapies
Trier, A. M., & Kim, B. (2022) · British Journal of Dermatology · doi:10.1093/bjd/ljac016 · Cited by 32
Johnson, H., Aquino, M., Snyder, A., Collis, R. W., França, K., Goldenberg, A., Sui, J. Y., Eichenfield, D. Z., Kozy, B. J., Chen, J. K., et al. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.06.048 · Cited by 32
Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Migliavaca, C. B., Lazzarini, R., Stein, C., Escher, G. N., de Gaspari, C. N., dos Santos, H. W. G., Myers, D. E., Lemeshow, A. R., Pinheiro, M. R. T., Falavigna, M., et al. (2024) · Dermatitis · doi:10.1089/derm.2024.0165 · Cited by 31
Skincare interventions in infants for preventing eczema and food allergy
Kelleher, M. M., Cro, S., Cornelius, V. R., Axon, E., Carlsen, K. C. L., Skjerven, H. O., Rehbinder, E. M., Lowe, A. J., Dissanayake, E., Shimojo, N., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013534 · Cited by 31
la Torre, R. S.-D., Fernández‐González, A., Quiñones-Vico, M. I., Montero‐Vílchez, T., & Arias‐Santiago, S. (2020) · Biomedicines · doi:10.3390/biomedicines8110464 · Cited by 31
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors
Arehart, C. H., Daya, M., Campbell, M., Boorgula, M. P., Rafaels, N. M., Chavan, S., David, G. L., Hanifin, J. M., Slifka, M. K., Gallo, R. L., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.034 · Cited by 31
Griffiths, C. E. M., de Bruin-Weller, M. S., Deleuran, M. S., Fargnoli, M. C., Staumont-Sallé, D., Hong, C.-H., Sánchez‐Carazo, J. L., Foley, P. A., Seo, S. J., Msihid, J., et al. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00558-0 · Cited by 30
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis
Calabrese, L., Chiricozzi, A., SIMONE, C. D., Fossati, B., D'Amore, A., & Peris, K. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2099835 · Cited by 30
Histamine Activates Human Eosinophils via H2R and H4R Predominantly in Atopic Dermatitis Patients
Beyer, L., Kabatas, A. S., Mommert, S., Stark, H., Werfel, T., Gutzmer, R., & Schaper‐Gerhardt, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810294 · Cited by 29
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis
Schneeweiss, M. C., Perez-Chada, L. M., & Merola, J. F. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.05.073 · Cited by 29
Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis
Ferrucci, S. M., Tavecchio, S., Angileri, L., Surace, T., Berti, E., & Buoli, M. (2021) · Acta Dermato Venereologica · doi:10.2340/00015555-3922 · Cited by 29
Koszorú, K., Hajdu, K., Brodszky, V., Bató, A., Gergely, L. H., Kovács, A., Beretzky, Z., Sárdy, M., Szegedi, A., & Rencz, F. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01460-y · Cited by 29
Burden of Disease; the Current Status of the Diagnosis and Management of Atopic Dermatitis in China
Gu, C., Yao, X., & Li, W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165370 · Cited by 29
Self-citationThe pathology of type 2 inflammation-associated itch in atopic dermatitis
Moniaga, C. S., Tominaga, M., & Takamori, K. (2021) · Diagnostics · doi:10.3390/diagnostics11112090 · Cited by 28
Lifelong Impact of Severe Atopic Dermatitis on Quality of Life: A Case Report
Bashyam, A. M., Ganguli, S., Mahajan, P. S., & Feldman, S. R. (2021) · Dermatology and Therapy · doi:10.1007/s13555-021-00515-x · Cited by 28
Tsagareli, M. G., Follansbee, T., Carstens, M. I., & Carstens, E. E. (2023) · Pharmaceuticals · doi:10.3390/ph16121707 · Cited by 28
Longitudinal course and predictors of depressive symptoms in atopic dermatitis
Chatrath, S., Lei, D. K., Yousaf, M., Chavda, R., Gabriel, S., & Silverberg, J. I. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.04.061 · Cited by 28
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
Blauvelt, A., Kircik, L., Papp, K. A., Simpson, E. L., Silverberg, J. I., Kim, B., Kwatra, S. G., Kuligowski, M. E., Venturanza, M. E., Wei, S., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18571 · Cited by 28
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study
Bissonnette, R., DuBois, J. C., Facheris, P., DUCA, E. D., Kim, M., da Rosa, J. C., Trujillo, D. L., Bose, S. N., Pagan, A. D., Wustrow, D. J., et al. (2023) · Allergy · doi:10.1111/all.15949 · Cited by 28
Societal costs and health related quality of life in adult atopic dermatitis
Beretzky, Z., Koszorú, K., Rencz, F., Hajdu, K., Borza, J., Bodai, K., Feifei, X., Szegedi, A., Sárdy, M., & Brodszky, V. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09840-7 · Cited by 27
Kim, J. E., Shin, M. K., Park, G., Lee, U. H., Lee, J. H., Han, T. Y., Ko, H., Jang, Y. H., Kim, H. O., Na, C. H., et al. (2019) · Annals of Dermatology · doi:10.5021/ad.2019.31.6.654 · Cited by 27
Agboola, F. O., Atlas, S. J., Brouwer, E., Carlson, J. J., Hansen, R. N., Herron-Smith, S., Nhan, E., Rind, D. M., & Pearson, S. D. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.1.108 · Cited by 27
Gabes, M., Tischer, C., Apfelbacher, C., & for the quality of life working group of the Harmonising Outcome Measures for Eczema (HOME) initiative (2019) · Pediatric Allergy and Immunology · doi:10.1111/pai.13120 · Cited by 28
Use of Dexpanthenol for Atopic Dermatitis—Benefits and Recommendations Based on Current Evidence
Cho, Y. S., Kim, H. O., Woo, S. M., & Lee, D. H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11143943 · Cited by 26
Association of atopic dermatitis with suicide risk among 788,411 adolescents
Kyung, Y., Choi, M. H., Jeon, Y. J., Lee, J. S., Lee, J. H., Jo, S. H., & Kim, S. H. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.03.023 · Cited by 26
Atopic dermatitis and bone health: a systematic review
Mukovozov, I., Morra, D. E., Giustini, D., Tadrous, M., Cheung, A. M., & Drucker, A. M. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16895 · Cited by 26
Self-citationCather, J. C., Young, M. S., DiRuggiero, D., Tofte, S. J., Williams, L., & Gonzalez, T. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00778-y · Cited by 27
Volke, A., Toompere, K., Laisaar, K.-T., Oona, M., Tisler, A., Johannson, A., Kallavus, K., Lang, K., Kiisk, E., & Uusküla, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-19508-7 · Cited by 26
Zozaya, N., Martínez-Galdeano, L., Alcalá, B., Hita, J. C. A., Carmona, C., Carrascosa, J. M., Herranz, P., Lamas, M. J., Trapero‐Bertran, M., & Hidalgo‐Vega, Á. (2018) · BioDrugs · doi:10.1007/s40259-018-0284-3 · Cited by 26
Wang, Y., Lu, H., Cheng, L., Guo, W., Hu, Y., Du, X., Liu, X., Xu, M., Liu, Y., Zhang, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155856 · Cited by 25
Health‐related behaviors and mental health states of South Korean adolescents with atopic dermatitis
Kyung, Y., Lee, J. S., Lee, J. H., Jo, S. H., & Kim, S. H. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15386 · Cited by 25
Sobczyk, M., Richardson, T. G., Zuber, V., Min, J. L., GoDMC, Gaunt, T. R., & Paternoster, L. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.03.027 · Cited by 28
Liang, J., Hu, F., Tang, H., Jiang, F.-H., Sang, Y., Hong, Y., Wang, Q., Nuer, K., & Kang, X. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18688 · Cited by 25
Air pollution and global healthcare use for atopic dermatitis: A systematic review
Fadadu, R. P., Chee, E., Jung, A., Chen, J. Y., Abuabara, K., & Wei, M. L. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19193 · Cited by 26
Changing perspectives in atopic dermatitis
Serra‐Baldrich, E., de Frutos, F. J. O., Jauregui, I., Hita, J. C. A., Silvestre, J. F., Herraez, L., Martin‐Santiago, A., Valero, A., & Sastre, J. (2017) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2017.07.002 · Cited by 25
Comorbilidades en dermatitis atópica: actualización y controversias
Carrascosa, J. M., & Morillas‐Lahuerta, V. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2020.04.009 · Cited by 25
Integrated behavioral health care for management of stress in allergic diseases
Oland, A. A., Booster, G. D., & Bender, B. G. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.05.002 · Cited by 24
Wu, K. K., Borba, A. J., Deng, P. H., & Armstrong, A. W. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1659480 · Cited by 24
Patient and caregiver preferences on treatment attributes for atopic dermatitis
Ervin, C. M., Crawford, R., Evans, E., Feldman, S. R., Zeichner, J., Zielinski, M. A., Cappelleri, J. C., DiBonaventura, M., Takiya, L., & Myers, D. E. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1940810 · Cited by 24
The direct and indirect costs of adult atopic dermatitis
Manjelievskaia, J., Boytsov, N. N., Brouillette, M. A., Onyekwere, U., Pierce, E. J., Goldblum, O. M., & Bonafede, M. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.10.1416 · Cited by 24
Social Media Platforms Listening Study on Atopic Dermatitis: Quantitative and Qualitative Findings
Voillot, P., Riche, B., Portafax, M., Foulquié, P., Gedik, A., Barbarot, S., Misery, L., Héas, S., Mebarki, A., Texier, N., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/31140 · Cited by 24
Borzutzky, A., Larco, J. I., Luna, P. C., McElwee, E., Pires, M. C., Rico-Restrepo, M., Sáez‐de‐Ocariz, M., & Sánchez, J. (2022) · Dermatitis · doi:10.1097/der.0000000000000904 · Cited by 24
Management of Atopic Dermatitis: The Role of Tacrolimus
Umar, B. U., Rahman, S., Dutta, S., Islam, T., Nusrat, N., Chowdhury, K., Fakuradzi, W. F. S. W. A., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.28130 · Cited by 24
Adjunctive Management of Itch in Atopic Dermatitis
Elmariah, S. B. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.02.011 · Cited by 24
Evolving Concepts in Atopic Dermatitis
Sidbury, R., & Khorsand, K. O. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0710-5 · Cited by 24
Choi, J.-Y., Dawe, R. S., Ibbotson, S. H., Fleming, C., Doney, A. S. F., & Foerster, J. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18265 · Cited by 24
Zhang, J., Loman, L., Oldhoff, M., & Schuttelaar, M. L. A. (2022) · Clinical and Experimental Dermatology · doi:10.1111/ced.15212 · Cited by 24
Wang, S., Wang, Y., Han, B., Chen, Y., Bai, X., Yu, S., & Liu, M. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154372 · Cited by 23
Lee, H. J., Lee, G.-N., Lee, J. H., Han, J. H., Han, K., & Park, Y. M. (2023) · Acta Dermato Venereologica · doi:10.2340/actadv.v103.2242 · Cited by 23
Neuropsychiatric disorders in adults with atopic dermatitis: A population‐based cohort study
Wan, J., Wang, S., Shin, D. B., Syed, M. N., Abuabara, K., Lemeshow, A. R., & Gelfand, J. M. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19518 · Cited by 22
Leong, K., Ong, T. W. Y., Foong, Y., Wong, Y.-P., Lim, W., Liew, H. M., & Koh, M. J. A. (2020) · Journal of Dermatological Treatment · doi:10.1080/09546634.2020.1782321 · Cited by 21
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis
Silverberg, J. I., Guttman‐Yassky, E., Gooderham, M., Worm, M., Rippon, S., O’Quinn, S., van der Merwe, R., Kragh, N., Kurbasic, A., & Wollenberg, A. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.12.004 · Cited by 21
Calzavara‐Pinton, P., on behalf of RADAR Group, Fortina, A. B., Bonamonte, D., Marseglia, G. L., del Giudice, M. M., Musarra, A., Nettis, E., Neri, I., Patruno, C., et al. (2021) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.20.06654-7 · Cited by 22
Silverberg, J. I., Feldman, S. R., Begolka, W. S., Johnson, M. B., Stanojev, C., DiBonaventura, M., Cella, R. R., Valdez, H., Feeney, C., & Thyssen, J. P. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18442 · Cited by 21
Kishi, R., Toyama, S., Tominaga, M., Kamata, Y., Komiya, E., Kaneko, T., Suga, Y., & Takamori, K. (2023) · Cells · doi:10.3390/cells12020239 · Cited by 21
Metadata
- Authors
- Drucker, A. M., Wang, A. R., Li, W.-Q., Sevetson, E., Block, J. K., & Qureshi, A. A.
- Affiliations
- Brown University (US)
- National Eczema Association (US)
- Corresponding author
- Drucker, Aaron M.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 137
- Issue
- 1
- Pages
- 26-30
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2520198258
- Cited by
- 720
- References
- 42
- Citations by year
- 2026: 63 · 2025: 64 · 2024: 110 · 2023: 94 · 2022: 92 · 2021: 99 · 2020: 80 · 2019: 49 · 2018: 30 · 2017: 36
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eczema Association
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- atopic dermatitis, disease burden, quality of life, economic burden, health care costs, occupational impact, research impact, social impact, family impact, patient-reported outcomes
- MeSH terms
- Adult, Child, Chronic Disease, Dermatitis, Atopic, Eczema, Female, Humans, Male, Quality of Life, Societies, Medical, United States, Health Care Costs, Cost of Illness, Sickness Impact Profile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review